The sickle cell disease implementation consortium : Translating evidence-based guidelines into practice for sickle cell disease
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
American journal of hematology - 93(2018), 12 vom: 02. Dez., Seite E391-E395 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
DiMartino, Lisa D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.08.2019 Date Revised 31.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ajh.25282 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM288408322 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM288408322 | ||
| 003 | DE-627 | ||
| 005 | 20231225060231.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.25282 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0961.xml |
| 035 | |a (DE-627)NLM288408322 | ||
| 035 | |a (NLM)30203558 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a DiMartino, Lisa D |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The sickle cell disease implementation consortium |b Translating evidence-based guidelines into practice for sickle cell disease |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.08.2019 | ||
| 500 | |a Date Revised 31.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 700 | 1 | |a Baumann, Ana A |e verfasserin |4 aut | |
| 700 | 1 | |a Hsu, Lewis L |e verfasserin |4 aut | |
| 700 | 1 | |a Kanter, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Gordeuk, Victor R |e verfasserin |4 aut | |
| 700 | 1 | |a Glassberg, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Treadwell, Marsha J |e verfasserin |4 aut | |
| 700 | 1 | |a Melvin, Cathy L |e verfasserin |4 aut | |
| 700 | 1 | |a Telfair, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Klesges, Lisa M |e verfasserin |4 aut | |
| 700 | 1 | |a King, Allison |e verfasserin |4 aut | |
| 700 | 1 | |a Wun, Ted |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Nirmish |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, Robert W |e verfasserin |4 aut | |
| 700 | 1 | |a Hankins, Jane S |e verfasserin |4 aut | |
| 700 | 0 | |a Sickle Cell Disease Implementation Consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d 1993 |g 93(2018), 12 vom: 02. Dez., Seite E391-E395 |w (DE-627)NLM000124354 |x 1096-8652 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2018 |g number:12 |g day:02 |g month:12 |g pages:E391-E395 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajh.25282 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 93 |j 2018 |e 12 |b 02 |c 12 |h E391-E395 | ||